Navigation Links
Health Reform Bill Should Include Clinical Preventive Services, Businesses and Health Advocates Urge Congressional Leaders
Date:5/4/2009

Cost-effective services often under-utilized

WASHINGTON, May 4 /PRNewswire-USNewswire/ -- More than a dozen health advocacy organizations and businesses from across the country Monday urged congressional leaders to provide coverage and incentives for clinical preventive services such as immunizations, disease screenings, and behavioral counseling as part of health reform legislation.

"Widespread delivery of effective clinical preventive services would help millions of Americans live longer and healthier lives," the group said in a letter to Senate Majority Leader Harry Reid and House Speaker Nancy Pelosi.

"Because recommended clinical preventive services improve health at a very reasonable cost, we urge you both to cover these services in existing federal health care programs, and to make coverage for effective preventive services an important part of health reform."

Many preventive services are currently under-utilized, even though they are known to be effective, the group said. They cited a study by the National Commission on Prevention Priorities that found that 100,000 lives would be saved each year if the use of just five important preventive services were increased from current levels to 90% of the target population. Those services were adult influenza immunization, aspirin counseling for cardiovascular health, tobacco counseling, breast cancer screening, and colorectal cancer screening.

Specifically, the group made the following recommendations:

  • Provide benefits under the Federal Employees Health Benefits Program, the Department of Defense, the Department of Veterans Affairs, and the Indian Health Service to cover clinical preventive services recommended by the US Preventive Services Task Force (USPSTF) and the Advisory Committee on Immunization Practices (ACIP).
  • Create incentives for, or require, states to cover co
    '/>"/>

SOURCE Partnership for Prevention
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Penn study finds pro-death proteins required to regulate healthy immune function
2. UCLA researchers identify markers that may predict diabetes in still-healthy people
3. Air pollution linked to cardiovascular risk indices in healthy young adults
4. More proof needed of safety and quality of electronic personal health records
5. Health care incentive model offers collaborative approach
6. Loneliness is bad for your health
7. Mailman School of Public Health study examines link between racial discrimination and substance use
8. Green Tea May Brew Up Healthier Skin
9. For Health Info, Women Often Turn to the Web
10. Record Number of Americans Lack Health Insurance
11. U.S. Research Funding Continues to Flatten as U.S. Health Costs Climb - in August 31 Science
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine News(10 mins):Health News:Daniel Simon, MD Urges People with Diabetes to Protect Sight by Getting Diabetic Eye Exam 2Health News:Daniel Simon, MD Urges People with Diabetes to Protect Sight by Getting Diabetic Eye Exam 3Health News:BioVeda Health and Wellness Center of Spring Hill, TN Announces Its Grand Opening 2Health News:BioVeda Health and Wellness Center of Spring Hill, TN Announces Its Grand Opening 3Health News:BioVeda Health and Wellness Center of Spring Hill, TN Announces Its Grand Opening 4Health News:BioVeda Health and Wellness Center of Spring Hill, TN Announces Its Grand Opening 5Health News:Registered Dietitians Identify Diet 'Gaps' - and How to Handle Them 2Health News:Registered Dietitians Identify Diet 'Gaps' - and How to Handle Them 3Health News:Nutraceutical Reports Fiscal 2009 Year End Results 2Health News:Nutraceutical Reports Fiscal 2009 Year End Results 3Health News:Nutraceutical Reports Fiscal 2009 Year End Results 4Health News:Nutraceutical Reports Fiscal 2009 Year End Results 5Health News:Nutraceutical Reports Fiscal 2009 Year End Results 6Health News:Nutraceutical Reports Fiscal 2009 Year End Results 7Health News:Nutraceutical Reports Fiscal 2009 Year End Results 8Health News:Fastrack Announces Major Expansion 2Health News:Fastrack Announces Major Expansion 3
Breaking Medicine Technology:Perrigo Confirms Filing for Generic Version of Clobex(R) Spray and Announcement of Lawsuit by Galderma and Dermalogix 2Perrigo Confirms Filing for Generic Version of Clobex(R) Spray and Announcement of Lawsuit by Galderma and Dermalogix 3Repligen Reports Phase 3 Clinical Trial Results of RG1068 in Pancreatic Imaging 2Repligen Reports Phase 3 Clinical Trial Results of RG1068 in Pancreatic Imaging 3Repligen Reports Phase 3 Clinical Trial Results of RG1068 in Pancreatic Imaging 4Springer launches SpringerImages 9172 1Springer launches SpringerImages 9172 2Improving Care for Cardiac Patients is Centerpiece of American Society of Nuclear Cardiology Meeting 51101 1Improving Care for Cardiac Patients is Centerpiece of American Society of Nuclear Cardiology Meeting 51101 2American Optometric Association Supports New Federal Health Report Findings 3A Vision Screening Methods for Seniors are Lacking 51097 1American Optometric Association Supports New Federal Health Report Findings 3A Vision Screening Methods for Seniors are Lacking 51097 2American Optometric Association Supports New Federal Health Report Findings 3A Vision Screening Methods for Seniors are Lacking 51097 3
Other Medicine Technology:Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase,II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple,Myeloma and Waldenstrom's Macroglobulinemia 2Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase,II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple,Myeloma and Waldenstrom's Macroglobulinemia 3Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase,II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple,Myeloma and Waldenstrom's Macroglobulinemia 4Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase,II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple,Myeloma and Waldenstrom's Macroglobulinemia 5Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase,II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple,Myeloma and Waldenstrom's Macroglobulinemia 6Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase,II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple,Myeloma and Waldenstrom's Macroglobulinemia 7RTA 402 Shown to Protect Animals Against Toxicities of Standard,Cancer Treatments 2RTA 402 Shown to Protect Animals Against Toxicities of Standard,Cancer Treatments 3